Back to IKT
GEODE CAPITAL MANAGEMENT, LLC → IKT
GEODE CAPITAL MANAGEMENT, LLC IKT Position History
Inhibikase Therapeutics, Inc. • Healthcare
Quarters held
10
Latest value
$906K
Q3 2026
Peak value
$5.4M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $1.6M |
| Q3 2025 | $205K |
| Q4 2025 | $2M |
| Q4 2025 | $287K |
| Q1 2026 | $3.1M |
| Q1 2026 | $547K |
| Q2 2026 | $4.6M |
| Q2 2026 | $741K |
| Q3 2026 | $5.4M |
| Q3 2026 | $906K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $906K | 440.8K | — | — |
| Q3 2026 | $5.4M | 2.62M | — | — |
| Q2 2026 | $741K | 365.2K | — | — |
| Q2 2026 | $4.6M | 2.24M | — | — |
| Q1 2026 | $547K | 325.6K | — | — |
| Q1 2026 | $3.1M | 1.84M | — | — |
| Q4 2025 | $287K | 140.1K | — | — |
| Q4 2025 | $2M | 988.1K | — | — |
| Q3 2025 | $205K | 126.7K | — | — |
| Q3 2025 | $1.6M | 985.9K | — | — |